Baiardi et al.142 found that plasma GFAP, measured using the Simoa SR-X platform, could differentiate Alzheimer’s disease from frontotemporal dementia and supranuclear palsy with respective receiver operating characteristic (ROC) curve AUCs of 0.82 and 0.77, respectively. The gene discussed is GFAP; the disease is Alzheimer disease.